Plasma total homocysteine in Brazilian overweight and non-overweight adolescents: A case-control study

Nutricion Hospitalaria

Volumn 20, Issue 5, 2005, Pages 313-319

  Brasileiro, R S ^a,b   Escrivao M A M S ^a,b   Taddei, J A A C ^a,b,e   D'Almeida, V ^a,c   Ancona Lopez, F ^a,b   Carvalhaes, J T A ^a,d  

^a Federal University of Sao   (Brazil)

^b Discipline of Nutrition and Metabolism   (Brazil)

^c Discipline of Genetics

^d Discipline of Pediatric Specialties

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescence; Folate; Homocysteine; Insulin resistance; Lipid profile; Obesity; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENCE; ADOLESCENT; AMINO ACID BLOOD LEVEL; ARTICLE; BRAZIL; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; SOCIOECONOMICS; BLOOD; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; BRAZIL; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; OBESITY; RISK FACTORS; SOCIOECONOMIC FACTORS; VITAMIN B 12;

EID: 27744608740     PISSN: 02121611     EISSN: 02121611     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. World Health Organization: Obesity: preventing and managing the global epidemic. Report of the WHO Consultation on Obesity. WHO, Geneva, 1998.
2. Wang Y, Monteiro C, Popkin BM: Trends of obesity and underweight in older children and adolescents in the United States, Brazil, China, and Russia. Am J Clin Nutr 2002; 75: 971-7.
3. Troiano RP, Flegal KM, Kuczraarski RJ, Campbell SM, Johnson CL: Overweight prevalence and trends for children and adolescents: the National Health and Nutrition Examination Surveys 1963 to 1991. Arch Pediatr Adolesc Med 1995; 149: 1085-91.
4. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS: The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 1999; 103: 1175-82.
5. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey SG: Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study on the Boyd Orr cohort. Am J Clin Nutr 1998; 67: 1111-8.
6. Ministério da Saúde: Plano national para a promoção da alimentação adequada e do peso saudável. Ministério da Saúde, Brasília, DF, 1999.
7. Tungtrongchitr R, Pongpaew P, Tongboonchoo C and cols.: Serum homocysteine, B12 and folic acid levels in Thai overweight and obese subjects. Int J Vitam Nutr Res 2003; 73: 8-14.
8. Jacques PF, Bostom AG, Wilson PWF and cols.: Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73: 613-21.
9. 12 levels among school children in Taiwan: The Taipei Children Heart Study. Clinical Biochemistry 2002; 35: 495-8.
10. Osganian SK, Stampfer MJ, Spiegelman D and cols.: Distribution of and factors associated with serum homocysteine levels in children: child and adolescent trial for cardiovascular health. JAMA 1999; 281: 1189-96.
11. Gallistl S, Sudi K, Mangge H, Erwa W, Borkenstein M: Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care 2000; 23: 1348-52.
12. Hankey GJ, Eikelboom JW: Homocysteine and vascular disease. Lancet 1999; 354: 407-13.
13. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-8.
14. McCully KS, Wilson RB: Homocysteine theory of arteriosclerosis: Atherosclerosis 1975; 22: 215-27.
15. McCully KS: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-28.
16. Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31-62.
17. 2) - a correction. Am J Clin Nutr 1991; 54: 773.
18. Tanner JM: Growth at adolescence. 2nd ed. Backwell Scientific Publications, Oxford, UK, 1962.
19. Pfeiffer CM, Huff DL, Gunter EW: Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 1999; 45: 290-2.
20. Ueland PM, Refsum H, Stabler SP and cols.: Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79.
21. Friedewald WT, Levy RI, Fredrickson DS : Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
22. Matthews DR, Hosker JP, Rudenski AS and cols.: Homeostasis model assessment: insulin resistence and B-cell function from fasting plasma glucose and insulin levels in man. Diabetologia 1985; 28: 412-19.
23. de Laet C, Wautrecht JC, Brasseur D and cols.: Plasma homocysteine levels in a Belgian school-age population. Am J Clin Nutr 1999; 69: 968-72.
24. Bates CJ, Mansoor MA, Gregory J, Pentiev K, Prentice A: Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over. Br J Nutr 2002; 87: 71-9.
25. Fonseca VA, Fink LM, Kern PA: Insulin sensitivity and plasma homocysteine levels in non-diabetic obese and normal weight subjects. Atherosclerosis 2003; 167: 105-9.
26. Must A, Jacques PF, Rogers G, Rosenberg IH, Selhub J: Serum total homocysteine levels in children and adolescents: results from the third National Health and Nutrition Examination Survey (NHANES III). J Nutr 2003; 133: 2643-9.
27. Greenlund KJ, Srinivasan SR, Xu JH and cols.: Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children: the Bogalusa Heart Study. Circulation 1999; 99: 2144-9.
28. Nygard O, Vollset SE, Refsum H and cols.: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995; 274: 1526-33.
29. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
30. McCully KS: Homocysteine and vascular disease. Nat Med 1996; 56: 111-28.
31. Nygard O, Nordrehaug JE, Refsum H and cols.: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-6.
32. van Beynum IM, Smeitink JA, den Heijer M, te Poele Pothoff MT, Bolm HJ: Hyperhomocysteinemia: a risk factor for stroke in children. Circulation 1999; 99: 2070-2.
33. Jacques PF, Rosenberg IH, Rogers G and cols.: Serum total homocysteine levels in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999; 69: 482-9.
34. Morris MS, Jacques PF, Selhub J, Rosenberg IH: Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000; 15: 140-8.
35. Ubbink JB: Vitamin nutrition status and homocysteine: an atherogenic risk factor. Nutr Rev 1994; 52: 383-7.
36. Savage DG, Lindenbaum J, Stabler SP, Allen RH: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239-46.
37. Nygard O, Refsum H, Ueland PM, Vollset SE: Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67: 263-70.
38. Jacques PF, Sulsky SI, Sadowski JA and cols.: Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr 1993; 57: 182-9.
39. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine levels. N Engl J Med 1999; 340: 1449-54.
40. Malinow MR, Duell PB, Hess DL and cols.: Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998; 338: 1009-15.
41. Oakley GP: Delaying folic acid fortification of flour. BMJ 2002; 324: 1348-9.
42. Ray JG, Vermeulen MJ, Boss SC, Cole DE: Increased red cell folate levels in women of reproductive age after Canadian folic acid food fortification. Epidemiology 2002; 13: 238-40.
43. Selhub J, Jacques PF, Bostom AG, Wilson PWF, Rosenberg IH: Relationship between plasma homocysteine and vitamin status in the Framingham study population: impact of folic acid fortification. Public Health Rev 2000; 28: 117-45.
44. Agência Nacional de Vigilância Sanitária: Regulamento técnico para fortificação das farinhas de trigo e das farinhas de milho com ferro e ácido fólico. Resolução Anvisa RDC n.° 344, 13 dezembro 2002. Internet: http://www.anvisa.gov.br/ alimentos/farinha.htm (accessed 23 August 2004).
45. Weiss R, Dziura J, Burgert TS and cols.: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74.
46. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV: Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996; 39: 1489-97.
47. Gillum RF: Distribution of serum homocysteine and its association with parental history and cardiovascular risk factors at ages 12-16 years: the Third National Health and Nutrition Examination Survey. Ann Epidemiol 2004; 14: 229-33.
48. Abbasi F, Facchini F, Humphreys MH, Reaven GM: Plasma homocysteine levels in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 1999; 146: 175-8.
49. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG: Plasma total homocysteine levels are unrelated to insulin sensitivity and components of the Metabolic Syndrome in healthy men. J Clin Endocrinol Metab 2001; 86: 719-23.